MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
MicroTech Medical Hangzhou Co Ltd
Total Assets
MicroTech Medical Hangzhou Co Ltd
Total Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
|
Total Assets
¥2.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Total Assets
¥3.7B
|
CAGR 3-Years
18%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Total Assets
¥16.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
19%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Total Assets
¥59.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Total Assets
¥29B
|
CAGR 3-Years
9%
|
CAGR 5-Years
61%
|
CAGR 10-Years
42%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Total Assets
¥28B
|
CAGR 3-Years
39%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
MicroTech Medical Hangzhou Co Ltd
Glance View
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research, development, manufacture, and sale of diabetes management medical devices. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-10-19. The firm's products such as applicator insulin pump system (Equil), blood glucose monitoring system and continuous blood glucose monitoring system (AiDEX G7) have been commercialized. The firm's products, such as artificial pancreas, are in the process of research and development. The firm's products are sold to overseas markets such as the United States and the European Union.
See Also
What is MicroTech Medical Hangzhou Co Ltd's Total Assets?
Total Assets
2.3B
CNY
Based on the financial report for Dec 31, 2025, MicroTech Medical Hangzhou Co Ltd's Total Assets amounts to 2.3B CNY.
What is MicroTech Medical Hangzhou Co Ltd's Total Assets growth rate?
Total Assets CAGR 5Y
24%
Over the last year, the Total Assets growth was 8%.
